August 23, 2021

How to cast a smarter net

Taking a new approach to expert identification can reshape outcomes for life science teams.
KOL selection

For many pharmaceutical and medical device teams, KOL selection can go one of two ways: defaulting to the list of KOLs they always use or outsourcing the work to a third party. Problem is, there are drawbacks to both approaches. Going back to the same people over and over again lets you talk to the experts you know best – but they might not be the best people to provide insight on every topic or therapeutic area. And hiring a third party can be time-consuming and expensive.

Related Posts:

How pharma can master social listening during congresses

How pharma can master social listening during medical congresses

Leveraging real-time digital conversations to enhance pharma congress strategy
insights based culture

Creating a culture based on insights: challenges, solutions, the how and why

Prioritizing insights can help medical affairs teams rethink how they position themselves in the broader organization